|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/36 | |||
| A61K 31/00 |
| (11) | Patento numeris | 1706095 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05705784.6 |
| Europos patento paraiškos padavimo data | 2005-01-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-10-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-12-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/001371 |
| Data | 2005-01-14 |
| (87) | Numeris | WO 2005/072701 |
| Data | 2005-08-11 |
| (30) | Numeris | Data | Šalis |
| 537620 P | 2004-01-20 | US |
| (72) |
HUGHES, Patrick, M., US
OLEJNIK, Orest, US
WHITCUP, Scott, M., US
BURKE, James, A., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID |
| COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID |